Rimegepant (Nurtec ODT) now available for acute treatment of migraineRimegepant is the second oral “gepant” for acute migraine to be marketed in Canada following ubrogepant (Ubrelvy). QUIZ: What do you know about hives and angioedema?Test your knowledge on common skin conditions. Eight ways healthcare professionals should create safe spaces for patients: ISMP Canada Patients need inclusive healthcare spaces that are psychologically safe, the organization says. Prescription copy functions can lead to errors: Manitoba’s Safety IQ program The prescription copy function in pharmacy software can lead to errors, especially when a dose changes. Keto diet could reduce symptoms of bipolar disorder, schizophrenia A small study found that participants with serious mental illness significantly reduced their symptoms, lost weight and reversed metabolic syndrome. Drug news—April 2024 A review of new launches, new indications, new dosage forms and Health Canada advisories. New guidelines for oral immunotherapy for food allergies Recommendations will help doctors prepare families who plan to build up their child’s tolerance by gradually introducing small amounts of allergens. Time-delayed pharmacy safes immediately reduce robberies The implementation of time-delayed safes in all Ontario pharmacies has had an immediate effect. Pharmacy techs could play a larger role in safe use of complementary medicines With adequate education and supportive technologies, pharmacy technicians could support pharmacists in promoting safe use of traditional and complementary medicines. A natural deception: 3 marketing myths the supplement industry wants you to swallow These three major assumptions appear over and over in supplement marketing. First Previous 81 82 83 84 85 Next Last
